$INTS
Intensity Therapeutics, Inc. Common stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
$4.11
▲+5.93%+$0.230
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateIntensity Therapeutics, Inc. Common stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is INTS up today? It is at $4.11 (+5.93%), and our scanner flagged it 2 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment INTS spikes, and full due diligence on INTS — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $INTS 2 times in the last 30 days. Create a free account to track $INTS, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on INTS from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for INTS today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Talamo Joseph Officer | Acquired (grant/award) | +1K 0.03% of company | added 95% | 2K | $4K at $3.48 | Jun 30, 26 |
Wesolowski John M Officer | Acquired (grant/award) | +4K 0.1% of company | added 100% | 7K | $13K at $3.48 | Jun 30, 26 |
Bender Lewis H Officer | Acquired (grant/award) | +38K 1.2% of company | added 47% | 119K | $231K at $6.11 | Mar 26, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in biological products, (no diagnostic substances), closest in size first.
Here is the latest on INTS from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for INTS today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
INTS last traded at $4.11, up 5.93% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Intensity Therapeutics, Inc. Common stock (INTS) is next expected to report earnings on Thursday, November 5, 2026, about 46 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The INTS Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged INTS 2 times in the last 30 days.
INTS (Intensity Therapeutics, Inc. Common stock) trades on XNAS, with a market cap of about $13M in the Biological Products, (No Diagnostic Substances) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge INTS for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$INTS discussion
Sign in to ask a question or join the discussion.